Pharmacokinetics and bioequivalence of finasteride tablets in healthy subjects

Journal of China Pharmaceutical University

Volumn 34, Issue 6, 2003, Pages 569-572

  Huang, Xin ^a   Ding, Li ^a   Sheng, Jian Ping ^b   Jian, Long Hai ^a   Zhang, Zheng Xing ^a   Zhang, Yin Di ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bioequaivalence; Finasteride; HPLC ESI MS; Pharmacokinetics

Indexed keywords

ACETIC ACID ETHYL ESTER; AMMONIA; FINASTERIDE; METHANOL; SODIUM; SODIUM HYDROXIDE; WATER;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 29744464889     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Ptacek P, Macek J, Klima J. J Chromatogr B Biomed Sci Appl, 2000, 738 (2):305.
2. Fabians GM, Wellington R, Demian RI, et al. Bioequivalence study of finasteride[J]. Arzneim Forsch Drug Res, 2001,51(1):145-150.
3. Constanzer ML, Chavez CM, Matuszewski BK. Picogram determination of finasteride in human plasma and semen by high-performance liquid chrogmatography with atmopheric-pressue chemical-ionization tandem mass spectrometry[J]. Journal of Chromatography B, 1994,658:281-287.